Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation
Status:
RECRUITING
Trial end date:
2025-11-30
Target enrollment:
Participant gender:
Summary
This is a Phase III, longitudinal, multicenter, randomized, double-blind clinical trial designed to evaluate the efficacy and safety of a fixed-dose combination of celecoxib and acetaminophen compared to celecoxib monotherapy for the treatment of pain associated with acute exacerbations of osteoarthritis.
Phase:
PHASE3
Details
Lead Sponsor:
Laboratorios Silanes S.A. de C.V.
Treatments:
Acetaminophen CelE protein, bacteria Celecoxib Dipeptidyl-Peptidases and Tripeptidyl-Peptidases